title: Which combination should be preferred in the management of children with chronic hepatitis B infection?
authors.forename: Bunyamin
authors.initials: B
authors.lastname: Dikici
authors.forename: Aydin
authors.initials: A
authors.lastname: Ece
authors.forename: Mehmet
authors.initials: M
authors.lastname: Bosnak
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D003657:Decision Making; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine